Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Search Results to Mario L Santiago

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Santiago, Mario

PropertyValue
overview Our laboratory studies the interplay between the innate and adaptive immune response against retroviruses to conceptually advance vaccine and cure strategies against HIV/AIDS. We are specifically interested in “restriction factors” – host proteins that could directly inhibit retroviruses but we discovered also play critical roles in shaping adaptive immune responses. These factors could be regulated by Type I interferons, thus highlighting possibilities for clinical translation.

One or more keywords matched the following items that are connected to Santiago, Mario

Item TypeName
Academic Article IFN-a treatment inhibits acute Friend retrovirus replication primarily through the antiviral effector molecule Apobec3.
Concept Interferon-beta
Concept Interferon-gamma
Concept Receptor, Interferon alpha-beta
Concept Interferon-alpha
Concept Interferons
Concept Interferon Regulatory Factor-7
Concept Interferon Type I
Academic Article Interferon-a Subtypes in an Ex Vivo Model of Acute HIV-1 Infection: Expression, Potency and Effector Mechanisms.
Academic Article Interferon Alpha Subtype-Specific Suppression of HIV-1 Infection In Vivo.
Academic Article T Cell Production of IFN? in Response to TLR7/IL-12 Stimulates Optimal B Cell Responses to Viruses.
Academic Article Type I interferon signaling is required for the APOBEC3/Rfv3-dependent neutralizing antibody response but not innate retrovirus restriction.
Grant Apobec3 and the Neutralizing Antibody Response Against Pathogenic Retroviruses
Grant Innate Restriction Factor Modulation of Retrovirus-specific Humoral Immunity
Grant HIV-Associated Interferon Effector Mechanisms in the GALT
Grant Role of Type I IFNs in Mucosal HIV-1 Immunity and Pathogenesis
Academic Article SAMHD1 suppresses innate immune responses to viral infections and inflammatory stimuli by inhibiting the NF-?B and interferon pathways.
Academic Article A compartmentalized type I interferon response in the gut during chronic HIV-1 infection is associated with immunopathogenesis.
Academic Article A Protective Role for the Lectin CD169/Siglec-1 against a Pathogenic Murine Retrovirus.
Concept Interferon-Induced Helicase, IFIH1
Academic Article Commensal and Pathogenic Bacteria Indirectly Induce IL-22 but Not IFN? Production From Human Colonic ILC3s via Multiple Mechanisms.
Academic Article Different Biological Activities of Specific Interferon Alpha Subtypes.
Academic Article Diverse Immunomodulatory Effects of Individual IFNa Subtypes on Virus-Specific CD8+ T Cell Responses.
Academic Article HIV infection does not alter interferon a/? receptor 2 expression on mucosal immune cells.
Academic Article Systemic Expression of a Viral RdRP Protects against Retrovirus Infection and Disease.
Academic Article Qualitative Differences Between the IFNa subtypes and IFN? Influence Chronic Mucosal HIV-1 Pathogenesis.
Academic Article Interferon Resistance of Emerging SARS-CoV-2 Variants.
Academic Article Specialized interferon action in COVID-19.
Academic Article Interferon resistance of emerging SARS-CoV-2 variants.
Academic Article SRSF1 acts as an IFN-I-regulated cellular dependency factor decisively affecting HIV-1 post-integration steps.
Academic Article Regulation of human interferon signaling by transposon exonization.

Search Criteria
  • Interferons

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)